TELO – telomir pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Telomir Pharmaceuticals (TELO) was upgraded by Zacks Research to "hold".
Telomir Pharmaceuticals (NASDAQ:TELO) was upgraded by analysts at Wall S
Telomir Pharmaceuticals (NASDAQ:TELO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Telomir Pharmaceuticals (NASDAQ:TELO) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating on the stock.
Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models [Yahoo! Finance]
Form 8-K Telomir Pharmaceuticals, For: Mar 23
Form 10-K Telomir Pharmaceuticals, For: Dec 31
Form DEFM14A Telomir Pharmaceuticals,
Form DEFA14A Telomir Pharmaceuticals,
Form 8-K Telomir Pharmaceuticals, For: Feb 17
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.